The short answer
Whole arils provide fiber, potassium, and polyphenol-rich color and flavor.
- Evidence and scope
- Food context; study findings do not grade the whole food.
- Important limitation
- Juice and extract trials show variable cardiometabolic signals. Gut-microbiome urolithin metabotypes may explain part of the person-to-person variation, but individual response and clinical benefit are not yet predictable.
- Before deciding
- Whole fruit generally retains more fiber than juice. Juice and extracts are not nutritionally equivalent to the intact food.
01 / NUTRIENTS & FORM
Nutrient snapshot
The exact food form matters. Raw, cooked, drained, dried, fortified, and branded versions can have meaningfully different values.
Whole arils provide fiber, potassium, and polyphenol-rich color and flavor.
We have not assigned a specific composition record to this food yet. Values will appear only after the food description, preparation state, edible portion, and serving weight are verified.
How nutrient values will be verified
- Planned display basis
- Practical serving and per 100 g
- Planned nutrient fields
- Energy, protein, carbohydrate, fiber, fat, sodium, and the most relevant micronutrients
- Publication rule
- Show the database, record ID, food form, serving weight, and verification date
02 / RESEARCH
Evidence map: baseline and emerging signals
The current baseline stays visually separate from credible findings that are mechanistic, responder-dependent, small, or not yet replicated.
The general interpretation that does not depend on one unreplicated positive result. An established limitation is as important as an established benefit.
Worth knowing now, with the reason it is not yet treated as general guidance.
Impact of pomegranate juice on blood pressure: A systematic review and meta-analysis.
The abstract reports a qualified or outcome-specific signal. It does not establish a general health benefit beyond the tested form, population, comparator, and duration.
- Study design
- Systematic review and meta-analysis
- Tested form / scope
- Juice, powder, or processed form
- Editorial interpretation
- Juice and extract trials show variable cardiometabolic signals. Gut-microbiome urolithin metabotypes may explain part of the person-to-person variation, but individual response and clinical benefit are not yet predictable.
- Screening record
- One relevant human PubMed source was verified and classified. This is a source card, not a complete evidence synthesis or a count of favorable studies.
Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial.
After the higher extract dose, several cholesterol-related markers improved only in participants with urolithin metabotype B. The finding supports the possibility that gut-microbial metabolism helps explain why pomegranate studies produce different results between people.
- Study design
- Double-blind crossover randomized trial in 49 adults
- Tested form / scope
- Standardized pomegranate extract capsules
- Why this remains emerging
- This was a short, small extract study with subgroup findings. It does not prove that all urolithin A producers benefit, that whole pomegranate or juice has the same effect, or that consumers can predict their metabotype without testing.
Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population.
Only about 40% of participants converted pomegranate-juice precursors into detectable urolithin A after intake. Producers differed in gut-microbiome features, supporting genuine variation in the ability to make this metabolite from food.
- Study design
- Randomized human bioavailability study; 100 participants assessed with juice
- Tested form / scope
- Pomegranate juice challenge and direct urolithin A product
- Why this remains emerging
- This measured metabolite production and exposure, not a health outcome. The study sponsor commercializes direct urolithin A, and several authors reported employment, board, or advisory relationships with the sponsor.
Educational information only—not medical advice. Allergies, medicines, pregnancy, kidney disease, diabetes treatment, swallowing needs, and preparation safety can change what is appropriate.